Nonhormonal Treatments for Insomnia

  • Catherine C. Schuman
Part of the Current Clinical Neurology book series (CCNEU)


Insomnia is a common and growing complaint; 54% of adults report experiencing at least one symptom of insomnia a few nights a week, and 33% of adults report experiencing at least one symptom every night, according to the National Sleep Foundation’s 2005 Sleep in America poll (1) Of those adults experiencing at least one symptom of insomnia a few nights a week, women comprise 57%, whereas men comprise 51% (1), although women are 1.5 times more likely than men to experience insomnia when using full diagnostic criteria (2.)


Negative Thought Chronic Insomnia Primary Insomnia Sleep Restriction Progressive Muscle Relaxation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    National Sleep Foundation. Sleep in America Poll., 2005.
  2. 2.
    Doghramji, P.P., Detection of insomnia in primary care. J Clin Psychiatry, 2001;62(Suppl 10):18–26.PubMedGoogle Scholar
  3. 3.
    Anonymous, Sleep disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Washington DC: American Psychiatric Publishing. 2000:597–662.Google Scholar
  4. 3a.
    American Academy of Sleep Medicine, The International Classification of Sleep Disorders, Revised Diagnostic and Coding Manual. 2nd ed. Chicago, IL: Author; 2005.Google Scholar
  5. 3b.
    World Health Organization, F50-F59: Behavioural syndromes associated with psychological disturbances and physical factors. The International Statistical Classification of Diseases and Related Health Problems, 10th revision. 1992:174–197.Google Scholar
  6. 4.
    McClusky, H.Y., J.B. Milby, P.K. Scoitzer, V. Williams, and V. Wooten, Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. Am J Psychiatry, 1991;148(sn1):121–126.PubMedGoogle Scholar
  7. 5.
    Morin, C.M., C. Colecchi, J. Stone, R. Sood, and D. Brink, Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA, 1999;281(11):991–999.PubMedCrossRefGoogle Scholar
  8. 6.
    Smith, M.T., M.L. Perlis, A. Park, et al., Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry, 2002;159(1):5–11.PubMedCrossRefGoogle Scholar
  9. 7.
    Spielman, A.J., L.S. Caruso, and P.B. Glovinsky, A behavioral perspective on insomnia treatment. Psychiatr Clin North Am, 1987;10(4):541–553.PubMedGoogle Scholar
  10. 8.
    Bootzin, R.R. and Nicassio, P.M., Behavioral treatments for insomnia. In: Progress in Behavior Modification (ei]M._Hersen, R. Eissler, P. Miller, eds.). 1978:1–45.Google Scholar
  11. 9.
    Roehrs, T., E. Hollebeek, C. Drake, and T. Roth, Substance use for insomnia in metropolitan Detroit. J Psychosom Res, 2002;53(1):571–576.PubMedCrossRefGoogle Scholar
  12. 10.
    Weiler, J.M., J.R. Bloomfield, G.G. Woodworth, et al., Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med, 2000;132(5):354–363.PubMedGoogle Scholar
  13. 11.
    Hedner, J., R. Yaeche, G. Emilien, I. Farr, and E. Salinas, Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int J Geriatr Psychiatry, 2000;15(8):704–712.PubMedCrossRefGoogle Scholar
  14. 12.
    Israel, A.G. and J.A. Kramer, Safety of zaleplon in the treatment of insomnia. Ann Pharmacother, 2002;36(5):852–859.PubMedCrossRefGoogle Scholar
  15. 13.
    Krystal, A.D., J.K. Walsh, E. Laska, et al., Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep, 2003;26(7):793–799.PubMedGoogle Scholar
  16. 14.
    Mendelson, W.B., T. Roth, S. Cassella, et al., The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev, 2004;8(1):7–17.PubMedCrossRefGoogle Scholar
  17. 15.
    Saletu-Zyhlarz, G., P. Anderer, N. Brandstatter, et al., Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Neuropsychobiology, 2000;41(3):139–148.PubMedCrossRefGoogle Scholar
  18. 16.
    Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry, 2002;26(2):249–260.PubMedCrossRefGoogle Scholar
  19. 17.
    Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology, 2001;44(3):139–149.PubMedCrossRefGoogle Scholar
  20. 18.
    Montgomery, I., I. Oswald, K. Morgan, and K. Adam, Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol, 1983;16(2):139–144.PubMedGoogle Scholar
  21. 19.
    Zhdanova, I.V., R.J. Wortman, M.M. Regan, J.A. Taylor, J.P. Shi, and O.U. Leclair, Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab, 2001;86(10):4727–4730.PubMedCrossRefGoogle Scholar
  22. 20.
    Smits, M.G., E.E. Nagtegaal, J. van der Heijden, A.M. Coenen, and G.A. Kerkhof, Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol, 2001;16(2):86–92.PubMedCrossRefGoogle Scholar
  23. 21.
    Almeida Montes, L.G., H.P. Ontiveros Uribe, J. Cortes Sotres, and G. Heinze Martin, Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study. J Psychiatry Neurosci, 2003;28(3):191–196.PubMedGoogle Scholar
  24. 22.
    Arendt, J., Complex effects of melatonin. Therapie, 1998;53(5):479–488.PubMedGoogle Scholar
  25. 23.
    Sack, R.L., A.J. Lewy, and R.J. Hughes, Use of melatonin for sleep and circadian rhythm disorders. Ann Med, 1998;30(1):115–121.PubMedGoogle Scholar
  26. 24.
    Stone, B.M., C. Turner, S.L. Mills, and A.N. Nicholson, Hypnotic activity of melatonin. Sleep, 2000;23(5):663–669.PubMedGoogle Scholar
  27. 25.
    Doghramji, P.P., Treatment of insomnia with zaleplon, a novel sleep medication. Int J Clin Pract, 2001;55(5):329–334.PubMedGoogle Scholar
  28. 26.
    Donath, F., S. Quispe, K. Diefenbach, A. Maurer, I. Fietze, and I. Roots, Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry, 2000;33(2):47–53.PubMedCrossRefGoogle Scholar
  29. 27.
    Dorn, M., (Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study). Forsch Komplementarmed Klass Naturheilkd, 2000;7(2):79–84.PubMedCrossRefGoogle Scholar
  30. 28.
    Fussel, A., A. Wolf, and A. Brattstrom, Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res, 2000;5(9):385–390.PubMedGoogle Scholar
  31. 29.
    Ziegler, G., M. Ploch, A. Miettinen-Baumann, and W. Collett, Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia-a randomized, double-blind, comparative clinical study. Eur J Med Res, 2002;7(11):480–486.PubMedGoogle Scholar
  32. 30.
    Poyares, D.R., C. Guilleminault, M.M. Ohayon, and S. Tufik, Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry, 2002;26(3):539–545.PubMedCrossRefGoogle Scholar
  33. 31.
    Zammit, G., T. Roth, M. Erman, S. Sainati, S. Weigand, and J. Zhang, Polysomnography and outpatient study to determine the efficacy of Ramelten in adults with chronic insomnia. 2005;227.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Catherine C. Schuman
    • 1
  1. 1.Departments of Neurology and PsychiatryUniversity of Vermont College of Medicine and Fletcher Allen Health CareBurlington

Personalised recommendations